BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 1309854)

  • 1. The open reading frames in the 3' long terminal repeats of several mouse mammary tumor virus integrants encode V beta 3-specific superantigens.
    Pullen AM; Choi Y; Kushnir E; Kappler J; Marrack P
    J Exp Med; 1992 Jan; 175(1):41-7. PubMed ID: 1309854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mls-1 is encoded by the long terminal repeat open reading frame of the mouse mammary tumor provirus Mtv-7.
    Beutner U; Frankel WN; Cote MS; Coffin JM; Huber BT
    Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5432-6. PubMed ID: 1319061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of mouse mammary tumor virus-induced T cell responses in vivo by antibodies to an open reading frame protein.
    Acha-Orbea H; Scarpellino L; Shakhov AN; Held W; MacDonald HR
    J Exp Med; 1992 Dec; 176(6):1769-72. PubMed ID: 1334118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An exogenous mouse mammary tumor virus with properties of Mls-1a (Mtv-7).
    Held W; Shakhov AN; Waanders G; Scarpellino L; Luethy R; Kraehenbuhl JP; MacDonald HR; Acha-Orbea H
    J Exp Med; 1992 Jun; 175(6):1623-33. PubMed ID: 1316932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mls-1-like superantigen in the MA/MyJ mouse is encoded by a new mammary tumor provirus that is distinct from Mtv-7.
    Rudy CK; Kraus E; Palmer E; Huber BT
    J Exp Med; 1992 Jun; 175(6):1613-21. PubMed ID: 1316931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. V beta 17 T-cell deletion by endogenous mammary tumor virus in wild-type-derived mouse strain.
    Jouvin-Marche E; Cazenave PA; Voegtle D; Marche PN
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3232-5. PubMed ID: 1314381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A superantigen encoded in the open reading frame of the 3' long terminal repeat of mouse mammary tumour virus.
    Choi Y; Kappler JW; Marrack P
    Nature; 1991 Mar; 350(6315):203-7. PubMed ID: 1706480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superantigen-reactive CD4+ T cells are required to stimulate B cells after infection with mouse mammary tumor virus.
    Held W; Shakhov AN; Izui S; Waanders GA; Scarpellino L; MacDonald HR; Acha-Orbea H
    J Exp Med; 1993 Feb; 177(2):359-66. PubMed ID: 8093892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production and characterization of an Mls-1-specific monoclonal antibody.
    Mohan N; Mottershead D; Subramanyam M; Beutner U; Huber BT
    J Exp Med; 1993 Feb; 177(2):351-8. PubMed ID: 8381154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules.
    Simpson E; Takacs K; Altmann DM
    Thymus; 1994; 23(1):1-13. PubMed ID: 7863543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel V beta 2-specific endogenous mouse mammary tumor virus which is capable of producing a milk-borne exogenous virus.
    Niimi N; Wajjwalku W; Ando Y; Nakamura N; Ueda M; Yoshikai Y
    J Virol; 1995 Nov; 69(11):7269-73. PubMed ID: 7474151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse mammary tumor viruses with functional superantigen genes are selected during in vivo infection.
    Golovkina TV; Dudley JP; Jaffe AB; Ross SR
    Proc Natl Acad Sci U S A; 1995 May; 92(11):4828-32. PubMed ID: 7761408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A V beta 8.2-specific superantigen from exogenous mouse mammary tumor virus carried by FM mice.
    Yoshimoto T; Nagase H; Nakano H; Matsuzawa A; Nariuchi H
    Eur J Immunol; 1994 Jul; 24(7):1612-9. PubMed ID: 7913038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of mammary tumor virus (Mtv)-negative and single-Mtv mice to evaluate the effects of endogenous viral superantigens on the T cell repertoire.
    Scherer MT; Ignatowicz L; Pullen A; Kappler J; Marrack P
    J Exp Med; 1995 Nov; 182(5):1493-504. PubMed ID: 7595219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of two V beta 7-specific viral superantigens.
    Ignatowicz L; Kappler JW; Marrack P; Scherer MT
    J Immunol; 1994 Jan; 152(1):65-71. PubMed ID: 8254207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of Mls-1.
    Beutner U; Rudy C; Huber BT
    Int Rev Immunol; 1992; 8(4):279-88. PubMed ID: 1318934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mls superantigens: how retroviruses influence the expressed T cell receptor repertoire.
    Huber BT
    Semin Immunol; 1992 Oct; 4(5):313-8. PubMed ID: 1336681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiologic expression of two superantigens in the BDF1 mouse.
    Gollob KJ; Palmer E
    J Immunol; 1991 Oct; 147(8):2447-54. PubMed ID: 1655891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human T cells respond to mouse mammary tumor virus-encoded superantigen: V beta restriction and conserved evolutionary features.
    Labrecque N; McGrath H; Subramanyam M; Huber BT; Sékaly RP
    J Exp Med; 1993 Jun; 177(6):1735-43. PubMed ID: 8388432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue-specific expression of messenger RNAs encoding endogenous viral superantigens.
    Jarvis CD; Germain RN; Hager GL; Damschroder M; Matis LA
    J Immunol; 1994 Feb; 152(3):1032-8. PubMed ID: 8301115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.